HLB Therapeutics Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Millions KRW. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Apr '26 Apr 9, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Market Capitalization	292,676	251,873	934,494	331,363	365,136	378,914
Market Cap Growth	-58.14%	-73.05%	182.02%	-9.25%	-3.64%	-51.22%
Enterprise Value	310,838	270,609	946,064	315,400	359,859	380,861
Last Close Price	3320.00	2857.14	10621.32	3977.32	4907.60	5990.56
PS Ratio	4.21	3.62	17.01	6.30	8.61	8.69
PB Ratio	1.68	1.45	5.14	1.93	2.85	2.91
P/TBV Ratio	2.12	1.82	6.37	2.21	3.28	3.31
P/FCF Ratio	-	-	1435.95	109.54	-	-
P/OCF Ratio	-	-	725.68	99.60	-	-
EV/Sales Ratio	4.47	3.89	17.22	6.00	8.49	8.74
EV/EBITDA Ratio	-	260.12	2022.13	-	-	-
EV/FCF Ratio	-32.85	-	1453.73	104.26	-	-
Debt / Equity Ratio	0.23	0.23	0.13	0.06	0.41	0.39
Debt / EBITDA Ratio	38.98	38.98	49.91	-	-	-
Debt / FCF Ratio	-	-	35.88	3.31	-	-
Net Debt / Equity Ratio	-0.03	-0.03	-0.08	-0.13	-0.09	-0.38
Net Debt / EBITDA Ratio	-5.24	-5.24	-30.82	57.35	2.03	5.27
Net Debt / FCF Ratio	0.58	0.58	-22.16	-7.38	0.97	4.09
Asset Turnover	0.31	0.31	0.26	0.27	0.23	0.28
Inventory Turnover	9.44	9.44	8.40	7.70	7.66	13.82
Quick Ratio	2.31	2.31	1.46	1.58	1.24	1.91
Current Ratio	2.84	2.84	1.70	1.86	1.37	2.00
Return on Equity (ROE)	-5.44%	-5.44%	-12.97%	-1.98%	-8.97%	-15.42%
Return on Assets (ROA)	-1.00%	-1.00%	-2.27%	-2.85%	-2.49%	-4.45%
Return on Capital Employed (ROCE)	-1.80%	-1.80%	-4.10%	-5.10%	-5.80%	-8.30%
Earnings Yield	-3.15%	-3.66%	-2.44%	-0.69%	-3.11%	-4.54%
FCF Yield	-3.23%	-3.76%	0.07%	0.91%	-3.34%	-3.19%
Buyback Yield / Dilution	-4.09%	-4.09%	-3.23%	-14.46%	-10.86%	-7.26%

Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.